Shenglan Qi
Impact in
-
- Medicinal Plants and Neuroprotection
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Synthesis and bioactivity of alkaloids 5
- Metabolomics and Mass Spectrometry Studies 3
-
- Cholinesterase and Neurodegenerative Diseases 2
- Flavonoids in Medical Research 2
- Co-authors
- Changhong Wang (12 shared papers)Xuemei Cheng (8 shared papers)Wei Liu (6 shared papers)Chao Ma (4 shared papers)Huida Guan (5 shared papers)Yuwen Wang (1 shared paper)Yunpeng Zhang (1 shared paper)Wenzheng Ding (1 shared paper)
- Journals
- Journal of Ethnopharmacology (8 papers)Frontiers in Pharmacology (4 papers)International Journal of Biological Macromolecules (2 papers)Phytomedicine (2 papers)Food Science and Human Wellness (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Shenglan Qi
28 papers receiving 376 citations
Peers
Comparison fields: 5 of 69
- Complementary and alternative medicine 43
- Pharmacology 81
- Pharmacology 43
- Biological Psychiatry 10
- Hepatology 20
Countries citing papers authored by Shenglan Qi
This map shows the geographic impact of Shenglan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Qi more than expected).
Fields of papers citing papers by Shenglan Qi
This network shows the impact of papers produced by Shenglan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Qi. The network helps show where Shenglan Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenglan Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 114 | |
| 2 | 2023 | 36 | |
| 3 | 2017 | 29 | |
| 4 | 2022 | 22 | |
| 5 | 2023 | 20 | |
| 6 | 2017 | 19 | |
| 7 | 2015 | 16 | |
| 8 | 2023 | 14 | |
| 9 | 2018 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2023 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2024 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2018 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2025 | 4 |
About Shenglan Qi
Shenglan Qi is a scholar working on Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, Epidemiology and Organic Chemistry, having authored 29 papers that have together received 381 indexed citations. Recurring topics across this work include Synthesis and bioactivity of alkaloids (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Flavonoids in Medical Research (2 papers), Liver Diseases and Immunity (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (43 citations), Pharmacology (81 citations), Pharmacology (43 citations), Biological Psychiatry (10 citations) and Hepatology (20 citations). Shenglan Qi has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Changhong Wang, Xuemei Cheng, Wei Liu, Chao Ma, Huida Guan, Yuwen Wang, Yunpeng Zhang, Wenzheng Ding, Shuping Li and Ping Liu. Their work appears in journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology, International Journal of Biological Macromolecules, Phytomedicine and Food Science and Human Wellness.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.